According to our findings, we identified exhausted CD8+ T cells in cycling status (CXCL13+MKI67+), which were relatively abundant in metastatic lymph nodes, implying that this particular subpopulation may serve as a potential therapeutic biomarker for metastatic ESCC. The gene discussed is CXCL13; the disease is esophageal squamous cell carcinoma.